Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Effect of Topiramate on Plasma Concentrations of Clozapine, Olanzapine, Risperidone, and Quetiapine in Patients With Psychotic Disorders.

Migliardi G, D'Arrigo C, Santoro V, Bruno A, Cortese L, Campolo D, Cacciola M, Spina E

*Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina; †IRCCS Centro Neurolesi "Bonino-Pulejo"; and ‡Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina, Messina, Italy.

OBJECTIVES:: To investigate the effect of topiramate on the steady-state plasma concentrations of the second-generation antipsychotics-clozapine, olanzapine, risperidone, and quetiapine-in patients with schizophrenia or bipolar disorder. METHODS:: Thirty-eight outpatients on long-term treatment with clozapine (250-500 mg/d, n = 10), olanzapine (10-20 mg/d, n = 12), risperidone (3-6 mg/d, n = 9), or quetiapine (200-600 mg/d, n = 7) received adjunctive topiramate, gradually titrated up to a final dosage of 200 mg/d for 6 weeks. Pharmacokinetic assessments were made at baseline and at the end of treatment weeks 4 and 8 at topiramate dosages of 100 and 200 mg/d, respectively. RESULTS:: Plasma concentrations of clozapine and its metabolite (norclozapine), olanzapine, risperidone and its metabolite (9-hydroxy-risperidone), and quetiapine were not significantly modified during concomitant administration of topiramate. Adjunctive topiramate therapy was well tolerated in all groups. CONCLUSIONS:: These findings indicate that topiramate, at the dosages recommended for use as a mood stabilizer, does not affect the plasma levels of the new antipsychotics-clozapine, olanzapine, risperidone, and quetiapine.

Published 6 April 2007 in Clin Neuropharmacol, 30(2): 107-113.
Full-text of this article is available online (may require subscription).

© 2004-2008 Bipolar Research Today. All Rights Reserved.